journal article·2024-11Open access

Multi‐Hierarchical Fe Single Atom Nanozymes with Axially‐Coordinated O‐Fe‐N4 Active Centers Reshape Macrophage Epigenetics Against Immunosuppression

Qin Wang, Xiaoqi Zhu, Binxu Yin, Kangning Yan, Guanhua Qiu, Xiayi Liang, Ruonan Jia, Jie Chen, Xiaobo Wang, Yafei Wu, Junjie Liu, Jingping Zhong, Kun Zhang, Duo Wang

Advanced Functional Materials· Volume 34· Issue 48

Abstract

Abstract Immunosuppression is ubiquitous in solid tumors, characterized by few cytotoxic T infiltrations, abundant inflammation enrichment, immunosuppressive cell recruitment, etc., which is especially potentiated by incomplete tumor resection. In this report, multi‐hierarchical Fe single‐atom nanozymes (SAzymes) featuring axially‐coordinated O‐Fe‐N4 active centers are constructed to reshape tumor‐associated macrophages (TAMs) epigenetics via repolarizing their phenotypes, which is highly profitable for mitigating tumor immunosuppression after incomplete radiofrequency ablation (iRFA). Therein, a nitrogen‐doped bamboo‐like carbon nanotube (N‐BCNT) is engineered to coordinatively immobilize Fe atoms, wherein another axial coordination (O) is introduced to further switch non‐polar Fe‐N4 to polar O‐Fe‐N4. The polarization switching of active centers synergies with N doping‐encouraged electron transport, low‐temperature synthesis‐discouraged N loss and large surface area‐unlocked O‐Fe‐N4 enrichment to confer tetra‐enzymic catalysis activities including peroxidase, oxidase, catalase, and glutathione oxidase, maximumly favoring reactive oxygen species (ROS) production and hypoxia reversal. After delivering TAMs polarization‐encouraged drug, toosendanin, TAMs epigenetics are altered and their phenotypes are repolarized to relieve immunosuppression and magnify immune responses, which suppress residual tumor progression after iRFA. Such a comprehensive structure optimization strategy provides a versatile route to design and construct SAzymes‐like drugs with multi‐enzymatical catalysis activities.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Ultrasound Department of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Guangxi Medical University. No. 71 Hedi Road Nanning 530021 P. R. China

Department of Medical Ultrasound and Central Laboratory Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital School of Medicine University of Electronic Science and Technology of China No. 32, West Second Section, First Ring Road Chengdu Sichuan 610072 P. R. China

Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co‐constructed By the Province and Ministry Guangxi Key Laboratory of Regenerative Medicine The First Affiliated Hospital of Guangxi Medical University No. 6 Shuangyong Road Nanning Guangxi 530021 P. R. China

Funding

National Natural Science Foundation of China · Sichuan Province Science and Technology Support Program · Natural Science Foundation of Guangxi Zhuang Autonomous Region · Guangxi Key Research and Development Program

References (50)

Show source-provided references
1. 10.1016/j.cej.2022.13638110.1016/j.cej.2022.136381 ↗
2. 10.1002/advs.20220392110.1002/advs.202203921 ↗
3. 10.1038/s41467-019-13204-310.1038/s41467-019-13204-3 ↗
4. 10.1002/adfm.20190692210.1002/adfm.201906922 ↗
5. 10.34133/research.010810.34133/research.0108 ↗
6. 10.1016/j.pmatsci.2023.10123010.1016/j.pmatsci.2023.101230 ↗
7. 10.1002/smsc.20230011110.1002/smsc.202300111 ↗
8. 10.1002/adfm.20230386910.1002/adfm.202303869 ↗
9. 10.1016/j.cej.2023.14555610.1016/j.cej.2023.145556 ↗
10. 10.1155/2022/508985710.1155/2022/5089857 ↗
11. 10.1016/j.nantod.2020.10100910.1016/j.nantod.2020.101009 ↗
12. 10.1038/s41565-018-0319-410.1038/s41565-018-0319-4 ↗
13. 10.1016/j.matt.2022.08.02610.1016/j.matt.2022.08.026 ↗
14. 10.1021/acsami.2c0944310.1021/acsami.2c09443 ↗
15. 10.1002/adfm.20231539410.1002/adfm.202315394 ↗
16. 10.1002/smll.20231122810.1002/smll.202311228 ↗
17. 10.1021/accountsmr.2c0010610.1021/accountsmr.2c00106 ↗
18. 10.1002/advs.20220310610.1002/advs.202203106 ↗
19. 10.1039/D2QM00960A10.1039/D2QM00960A ↗
20. 10.1002/anie.20220450210.1002/anie.202204502 ↗
21. 10.1021/jacs.2c1359710.1021/jacs.2c13597 ↗
22. 10.1002/advs.20230779810.1002/advs.202307798 ↗
23. 10.1002/advs.20230843910.1002/advs.202308439 ↗
24. 10.1002/adfm.20220939910.1002/adfm.202209399 ↗
25. 10.1016/j.nantod.2022.10153010.1016/j.nantod.2022.101530 ↗
26. 10.1038/s41467-023-43176-410.1038/s41467-023-43176-4 ↗
27. 10.1016/j.biomaterials.2021.12132510.1016/j.biomaterials.2021.121325 ↗
28. 10.1002/adfm.20220402510.1002/adfm.202204025 ↗
29. 10.1007/s12274-022-5211-810.1007/s12274-022-5211-8 ↗
30. 10.1016/j.electacta.2020.13703510.1016/j.electacta.2020.137035 ↗
31. 10.1038/s41467-023-42889-w10.1038/s41467-023-42889-w ↗
32. 10.1021/cs500062s10.1021/cs500062s ↗
33. 10.1021/cs300791j10.1021/cs300791j ↗
34. 10.1002/smll.20190148510.1002/smll.201901485 ↗
35. 10.1166/jnn.2005.30410.1166/jnn.2005.304 ↗
36. 10.3390/met1212205010.3390/met12122050 ↗
37. 10.1016/j.jhazmat.2020.12489910.1016/j.jhazmat.2020.124899 ↗
38. Xiao J. · Nanoscale. · 2015 · 7 · 7056
39. 10.1039/C6NR00534A10.1039/C6NR00534A ↗
40. 10.1016/j.pmatsci.2018.02.00210.1016/j.pmatsci.2018.02.002 ↗
41. 10.1021/ar300094m10.1021/ar300094m ↗
42. 10.1002/advs.20230868410.1002/advs.202308684 ↗
43. 10.1002/smll.20190310810.1002/smll.201903108 ↗
44. 10.1002/advs.20230257910.1002/advs.202302579 ↗
45. 10.1002/anie.20231677910.1002/anie.202316779 ↗
46. 10.1126/scitranslmed.abq355810.1126/scitranslmed.abq3558 ↗
47. 10.1002/smll.20140194310.1002/smll.201401943 ↗
48. 10.1039/d1034ee00173g10.1039/d1034ee00173g ↗
49. 10.1002/aenm.20160242010.1002/aenm.201602420 ↗
50. 10.1002/bmm2.1204310.1002/bmm2.12043 ↗